
Sign up to save your podcasts
Or


A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse.
Click for transcript
By Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more4.4
1818 ratings
A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse.
Click for transcript

32,000 Listeners

530 Listeners

761 Listeners

124 Listeners

320 Listeners

62 Listeners

86 Listeners

33 Listeners

147 Listeners

51 Listeners

12 Listeners

12 Listeners

15 Listeners

7 Listeners

36 Listeners